Chemotherapy for advanced ovarian cancer
Author:
Affiliation:
1. University of York; Centre for Reviews and Dissemination; York UK YO10 5DD
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD001418/fullpdf
Reference70 articles.
1. A randomised study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma;Aabo;European Journal of Cancer and Clinical Oncology,1985
2. Comparison of melphalan with cyclophosphamide, methotrexate and 5-fluorouracil in patients with ovarian cancer;Brodovsky;Cancer,1984
3. Controlled prospective trial of combination chemotherapy with cyclophosphamide, Adriamycin and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report;Bruckner;Cancer Treatment Reports,1979
4. A randomised comparison of melphalan versus melphalan plus hexamethylmelamine versus Adriamycin plus cyclophosphamide in ovarian carcinoma;Omura;Cancer,1983
5. Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of Cytoxan, 5-fluorouracil and dactinomycin;Park;Cancer,1980
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Relationships between CD34-, CD105- and bcl-2-Expression Levels and Contrast-Enhanced Ultrasound-Based Differential Diagnosis of Adnexal Tumours;Journal of Clinical Medicine;2023-11-28
2. Angiogenesis inhibitors for the treatment of epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2023-04-18
3. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer;Cochrane Database of Systematic Reviews;2022-02-16
4. Risk of recurrence of malignant tumors of the ovaries and levels of tumor markers НЕ-4 and СА-125;Український радіологічний та онкологічний журнал;2020-12-17
5. Epidermal growth factor receptor blockers for the treatment of ovarian cancer;Cochrane Database of Systematic Reviews;2018-10-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3